Life Science Leader - Academia Finds New Ways To Partner With Pharma

By: Jonathan P. Gertler and Christopher LeoBBLSA Senior Vice President, Chris Leo, and BBLSA Founder and CEO, Jonathan Gertler, wrote an article for the March issue of Life Science Leader: Academia Finds New Ways To Partner With Pharma.The article explores the increasing collaboration between academia and industry, as new approaches and creativity emerge. Subscribers can read the article in the March issue and online here.Leo and Gertler point out that through new partnering approaches and the rapid advance of our scientific knowledge, we are poised for an extraordinarily exciting decade ahead.Chris and Jonathan have many years of experience in strategic advisory, and expertise in the new academia-industry model.

Academia Finds New Ways To Partner With Pharma

By Christopher Leo, Ph.D., senior VP, and Jonathan Gertler, M.D., managing partner, founder, and CEO, Back Bay Life Science AdvisorsFor the past decade, academia and industry have become increasingly collaborative, finding ways to shed cautious attitudes and successfully advance programs together. Now, academia is taking a proactive, strategic approach that promises to further catalyze industry relationships and increase opportunities for commercialization and monetization of the most promising technologies.Academia has responded in kind with enthusiasm and measured pursuit to engage industry. Many institutions, including Stanford, Harvard, Johns Hopkins, and the University of California, San Francisco, have found creative ways to fund high-priority technologies toward development and commercialization, monetize potential royalty streams, and collaborate with industry beyond the traditional structures.